Back

ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy and severely impaired ejection fraction: pro

30 March 2025 (08:30 - 08:40)
Organised by: Logo
Congress Presentation Part of: Debate on primary prevention in ICD therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Valentina Kutyifa

University of Rochester, Rochester (United States of America)

5 More presentations in this session

Presentation thumbnail
ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy and severely impaired LVEF: con
Doctor N. Dagres (Berlin, DE)
Slides Video
Presentation thumbnail
ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy: discussion
Video
Presentation thumbnail
Do we need a prophylactic ICD in patients with CRT indication? pro
Doctor S. Al-Khatib (Durham, US)
Slides Video
Presentation thumbnail
Do we need a prophylactic ICD in patients with CRT indication? con
Professor C. Sticherling (Basel, CH)
Slides Video
Presentation thumbnail
Do we need a prophylactic ICD in patients with CRT indication? discussion
Video

Access the full session

Session thumbnail
Debate on primary prevention in ICD therapy
Video

The Event

Event poster

EHRA 2025

30 March 2025 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Limitations of current ICD indications in ischemic cardiomyopathy
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: pro
thumbnail
Congress Presentation
ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy and severely impaired LVEF: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources